CA2644547C — Devices, systems and methods for medicament delivery
Assigned to kaleo Inc · Expires 2017-01-03 · 9y expired
What this patent protects
An apparatus (1000) includes a housing (1100), a medicament container (9000) and an actuator (4000). The apparatus includes a label configured to be coupled to a medicament delivery device The label includes a first surface and a second surface. The first surfac configured to be …
USPTO Abstract
An apparatus (1000) includes a housing (1100), a medicament container (9000) and an actuator (4000). The apparatus includes a label configured to be coupled to a medicament delivery device The label includes a first surface and a second surface. The first surfac configured to be coupled to an outer surface of the medicament delivery device. The second surface includes a textual indicia (1400). The label further includes an electronic circuit system configured to output an electronic signal.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.